Mirna Therapeutics Researcher Says miRNA Replacement May Be Promising Rx Approach
June 19, 2008
Mirna Therapeutics Researcher Says miRNA Replacement May Be Promising Rx Approach
While most companies working in the microRNA drugs space are aiming to inhibit the small, non-coding RNAs, Mirna views miRNA-replacement therapy as a more promising therapeutic approach.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Regulus Selects HCV Drug Candidate, Will Develop without Partner GSK
May 16, 2013 / Gene Silencing News - Scripps, Novartis Team Uncovers New Details of Guide RNA, Argonaute2 Interaction
May 16, 2013 / Gene Silencing News - Gradalis Releases New Clinical Data on Cancer Vaccine
May 16, 2013 / Gene Silencing News - Former Traversa Exec Forms New Company to Develop Oligo-modification Tech
May 16, 2013 / Gene Silencing News - Tekmira on Track to Move Cancer Drug into Phase II, Name New Clinical Candidate in ‘13
May 16, 2013 / Gene Silencing News